References
Gordon A (1997) The increasing efficacy of breast cancer treatment. Clin Oncol (R Coll Radiol) 9:338–342
Genka S, Deutsch J, Stahle PL, Shetty UH, John V, Rapoport SI, Greig NH (1990) Brain and plasma pharmacokinetics and anti-cancer activities of cyclophosphamide and phosphoramide mustard in the rat. Cancer Chemother Pharmacol 27:1–7
Dautzenberg H, Schuldt U, Grasnick G, Karle P, Müller P, Löhr M, Pelegrin M, Piechaczyk M, Von Rombs K, Günzburg WH, Salmons B, Saller RM (1999) Development of cellulose sulphate based polyelectrolyte complex microcapsules for medical applications. Ann NY Acad Sci 875:46–63
Löhr JM, Hoffmeyer A, Kröger J-C, Freund M, Hain J, Holle A, Karle P, Knöfel WT, Liebe S, Müller P, Nizze H, Renner M, Saller RM, Wagner T, Hauenstein K, Günzburg WH, Salmons B (2001) Microencapsulated cell mediated therapy of inoperable pancreatic carcinoma. Lancet 357:1591–1592
Kammertöns T, Gelbmann W, Karle P, Saller R, Salmons B, Günzburg WH, Uckert W (2000) Combined chemotherapy of murine mammary tumors by local activation of the prodrugs ifosfamide and 5-fluorocytosine. Cancer Gene Ther 7:629–636
Günzburg WH, Karle P, Renz R, Salmons B, Renner M (1999) Characterisation of a human cell clone expressing cytochrome P450 for safe use in human somatic cell therapy. Ann NY Acad Sci 30:880:326–336
Perez Alenza MD, Pena L, Del Castillo N, Nieto AI (2000) Factors influencing the incidence and prognosis of canine mammary tumours. J Small Anim Pract 41:287–291
Brodey RS, Goldschmidt MH, Roszel JR (1983) Canine mammary gland neoplasms. J Am Anim Hosp Assoc 19:61–90
Simon D, Goronzy P, Stephan I, Meyer-Lindenberg A, Aufderheider M, Nolte I (1996) Mammatumoren beim Hund: Untersuchung zu Vorkommen und Verlauf der Erkrankung. Praktische Tierarzt 9:771–782
Kuntze A, Kuntze O (1993) Zur Chirurgie der Mammatumoren bei Hund und Katze. Mh Vet Med 48:467–472
Karayannopoulou M, Kaldrymidou E, Constantinidis TC, Dessiris A (2001) Adjuvant post-operative chemotherapy in bitches with mammary cancer. J Vet Med A Physiol Pathol Clin Med 48:85–96
Löhr M, Müller P, Karle P, Stange J, Mitzner S, Jesenowski R, Nizze H, Nebe B, Liebe S, Salmons B, Günzburg WH (1998) Targeted chemotherapy by encapsulating cells engineered to deliver CYP2B1, an ifosfamide activating cytochrome P450 gene. Gene Ther 5:1070–1078
Löhr JM, Bago ZT, Bergmeister H, Ceijka M, Freund M, Gelbmann W, Günzburg, WH, Hain J, Hauenstein K, Henniger W, Hoffmeyer A, Karle P, Kröger J-C, Liebe S, Losert U, Probst A, Renner M, Renz R, Saller R, Salmons B, Schuh M, Wagner T, Walter I (1999) Cell therapy using microencapsulated 293 cells transfected with a gene construct expressing CYP2B1, an ifosfamide converting enzyme, instilled intraarterially in patients with advanced stage carcinoma: phase I/II study. J Mol Med 77:393–398
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Winiarczyk, S., Gradski, Z., Kosztolich, B. et al. JMM — Past and Present. J Mol Med 80, 610–614 (2002). https://doi.org/10.1007/s00109-002-0356-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00109-002-0356-0